Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:752-761
Published online before print March 13, 2006, doi: 10.1161/01.HYP.0000214867.35632.0e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/4/752    most recent
01.HYP.0000214867.35632.0ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, C.-F.
Right arrow Articles by Chao, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, C.-F.
Right arrow Articles by Chao, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction

(Hypertension. 2006;47:752.)
© 2006 American Heart Association, Inc.


Original Articles

Postischemic Brain Injury Is Exacerbated in Mice Lacking the Kinin B2 Receptor

Chun-Fang Xia; Robert S. Smith, Jr; Bo Shen; Zhi-Rong Yang; Cesar V. Borlongan; Lee Chao; Julie Chao

From the Department of Biochemistry and Molecular Biology (C.-F.X., R.S.S., B.S., Z.-R.Y., L.C., J.C.), Medical University of South Carolina, Charleston; and Department of Neurology and Institute of Molecular Medicine and Genetics (C.V.B.), Medical College of Georgia, Augusta.

Correspondence to Julie Chao, PhD, Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Ave, Charleston, SC 29425. E-mail chaoj{at}musc.edu

Kallikrein cleaves low molecular weight kininogen to generate vasoactive kinins, which bind to the kinin B2 receptor, triggering a host of biological effects. Kallikrein gene delivery has been shown previously to reduce ischemia/reperfusion-induced cerebral infarction. In this study, we tested the hypothesis that the kinin B2 receptor plays a protective role in ischemic brain injury using kinin B2 receptor gene knockout (B2R-KO) mice subjected to middle cerebral artery occlusion (MCAO). The mortality rate and neurological deficit scores of B2R-KO mice (n=48) after MCAO were significantly increased compared with wild-type (WT) mice (n=40) when examined over a 14-day period. In addition, the infarct volume in B2R-KO mice was significantly larger than in WT mice at days 1 and 3 after MCAO. Similarly, apoptotic cells, detected by TUNEL labeling counterstained with propidium iodide, and caspase-3 activity in the ischemic brain increased significantly in B2R-KO mice at days 1 and 3 after MCAO. Furthermore, the accumulation of neutrophils in the ischemic brain of B2R-KO mice after MCAO increased when compared with WT mice and was associated with elevated tumor necrosis factor {alpha} expression. These alterations in B2R-KO mice correlated with decreased NO levels, Akt, and glycogen synthase kinase-3ß phosphorylation and increased nicotinamide-adenine dinucleotide oxidase activity. These results indicate that the kinin B2 receptor promotes survival and protects against brain injury by suppression of apoptosis and inflammation induced by ischemic stroke.


Key Words: kinins • stroke • apoptosis • cerebral ischemia • receptors, bradykinin




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. Sanchez de Miguel, S. Neysari, S. Jakob, M. Petrimpol, N. Butz, A. Banfi, C. E. Zaugg, R. Humar, and E. J. Battegay
B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart
Cardiovasc Res, July 21, 2008; (2008) cvn170v2.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Kleinschnitz, M. Austinat, M. Bader, T. Renne, and G. Stoll
Deficiency of Bradykinin Receptor B2 Is not Detrimental in Experimental Stroke
Hypertension, May 1, 2008; 51(5): e41 - e41.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Gailani and T. Renne
Intrinsic Pathway of Coagulation and Arterial Thrombosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2507 - 2513.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kakoki, R. W. McGarrah, H.-S. Kim, and O. Smithies
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
PNAS, May 1, 2007; 104(18): 7576 - 7581.
[Abstract] [Full Text] [PDF]